A novel TLR4-binding peptide that inhibits LPS-induced activation of NF-κB and in vivo toxicity
✍ Scribed by Kei-ichi Sugiyama; Masashi Muroi; Ken-ichi Tanamoto
- Book ID
- 113587803
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 450 KB
- Volume
- 594
- Category
- Article
- ISSN
- 0014-2999
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Multiple myeloma (MM) is a fatal lymphoid malignancy that is incurable with conventional modalities of chemotherapy. Strong and constitutive activation of nuclear factor kappa B (NF-kappaB) is a common characteristic of MM cells. In our study we successfully target NF-kappaB with a novel NF-kappaB i
## Abstract Opioids and the neuropeptide substance P (SP) modulate the expression of inflammatory cytokines and chemokines, which are under the control of nuclear factor κB (NF‐κB). We investigated whether the neurokinin‐1 receptor (SP receptor) pathway is biologically involved in morphine‐mediated